![Colin Keating](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Colin Keating
Amministratore Delegato presso MindBio Therapeutics Pty Ltd.
Profilo
Colin Keating currently works at MindBio Therapeutics Pty Ltd., as Chief Executive Officer.
Posizioni attive di Colin Keating
Società | Posizione | Inizio |
---|---|---|
MindBio Therapeutics Pty Ltd.
![]() MindBio Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology MindBio Therapeutics Pty Ltd. is a multi-award-winning leader in microdosing psychedelic medicines. The company is based in Melbourne, Australia, and has subsidiaries in Australia. MindBio Therapeutics is focused on creating treatments for mental health conditions, and its clinical trials focusing on microdosing psychedelic medicines provide hope for sufferers of mental health conditions. The Australian company has conducted a randomized, double-blind, placebo-controlled trial to study the effects of repeated microdoses of lysergic acid diethylamide (LSD) on creativity and brain activity in healthy adult males. MindBio Therapeutics was founded by Justin Adam Hanka, and the CEO is Colin Keating. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
MindBio Therapeutics Pty Ltd.
![]() MindBio Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology MindBio Therapeutics Pty Ltd. is a multi-award-winning leader in microdosing psychedelic medicines. The company is based in Melbourne, Australia, and has subsidiaries in Australia. MindBio Therapeutics is focused on creating treatments for mental health conditions, and its clinical trials focusing on microdosing psychedelic medicines provide hope for sufferers of mental health conditions. The Australian company has conducted a randomized, double-blind, placebo-controlled trial to study the effects of repeated microdoses of lysergic acid diethylamide (LSD) on creativity and brain activity in healthy adult males. MindBio Therapeutics was founded by Justin Adam Hanka, and the CEO is Colin Keating. | Health Technology |
- Borsa valori
- Insiders
- Colin Keating